These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8127057)

  • 1. Phenylalanine and other amino acids in phenylketonuria.
    Clemens PC; Burmester JG; Prankel BH; Wiegand G; Wulke AP; Plettner C
    J Inherit Metab Dis; 1993; 16(6):1045-6. PubMed ID: 8127057
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood amino acids in phenylketonuria. 11 cases].
    Farriaux JP; Fontaine G
    Ann Pediatr (Paris); 1969 Oct; 16(10):608-14. PubMed ID: 5357398
    [No Abstract]   [Full Text] [Related]  

  • 3. [Phenylalanine concentration in the cerebrospinal fluid and blood, both entering and leaving the brain, of phenylketonuria patients].
    Bulakhova LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1542-6. PubMed ID: 4775335
    [No Abstract]   [Full Text] [Related]  

  • 4. Biopterin derivatives in normal and phenylketonuric patients after oral loads of L-phenylalanine, L-tyrosine, and L-tryptophan.
    Leeming RJ; Blair JA; Green A; Raine DN
    Arch Dis Child; 1976 Oct; 51(10):771-7. PubMed ID: 1008581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acidic metabolites of phenylalanine in plasma of phenylketonurics.
    Tuchman M; Fisch RO; Ramnaraine ML; Krivit W
    Biochem Med; 1985 Oct; 34(2):203-6. PubMed ID: 4084243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular concentrations of phenylalanine, tyrosine and alpha-aminobutyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria (PKU) compared with 26 normals.
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    Hum Genet; 1980; 54(2):213-6. PubMed ID: 7390492
    [No Abstract]   [Full Text] [Related]  

  • 7. Content of phenylalanine, tyrosine and their metabolites in CSF in phenylketonuria.
    Antoshechkin AG; Chentsova TV; Tatur VYu ; Naritsin DB; Railian GP
    J Inherit Metab Dis; 1991; 14(5):749-54. PubMed ID: 1779620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An enzymatic assay of plasma phenylalanine and tyrosine for the detection and management of phenylketonuria.
    Shen RS; Richardson CJ; Rouse BM; Abell CW
    Biochem Med; 1981 Oct; 26(2):211-21. PubMed ID: 7317039
    [No Abstract]   [Full Text] [Related]  

  • 9. Benefits of mutation analysis and examination of brain phenylalanine levels in the management of phenylketonuria.
    Koch R; Güttler F
    Pediatrics; 2000 Nov; 106(5):1136. PubMed ID: 11061787
    [No Abstract]   [Full Text] [Related]  

  • 10. After a positive Guthrie--what next? Dietary management for the child with phenylketonuria.
    Clark BJ
    Eur J Clin Nutr; 1992 Jun; 46 Suppl 1():S33-9. PubMed ID: 1612049
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria.
    Arch Dis Child; 1993 Mar; 68(3):426-7. PubMed ID: 8466250
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenylketonemia in phenylketonuria.
    Partington MW; Vickery SK
    Neuropadiatrie; 1974 May; 5(2):125-37. PubMed ID: 4407755
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of a phenylalanine-restricted diet on phenylketonuria.
    Burgard P; Link R; Schweitzer-Krantz S
    Eur J Pediatr; 2000 Oct; 159 Suppl 2():S69. PubMed ID: 11221746
    [No Abstract]   [Full Text] [Related]  

  • 14. Dietary management of phenylketonuria from birth using a phenylalanine-free product.
    Flannery DB; Hitchcock E; Mamunes P
    J Pediatr; 1983 Aug; 103(2):247-9. PubMed ID: 6875718
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma phenylalanine in patients with phenylketonuria self-managing their diet.
    Bekhof J; van Rijn M; Sauer PJ; Ten Vergert EM; Reijngoud DJ; van Spronsen FJ
    Arch Dis Child; 2005 Feb; 90(2):163-4. PubMed ID: 15665170
    [No Abstract]   [Full Text] [Related]  

  • 16. Intracellular concentrations of phenylalanine, tyrosine and alpha-aminobutyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria compared with 26 normals.
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    J Inherit Metab Dis; 1981; 4(2):73-4. PubMed ID: 6790854
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma concentrations of phenyllactic acid in phenylketonuria.
    Clemens PC; Schünemann MH; Hoffmann GF; Kohlschütter A
    J Inherit Metab Dis; 1990; 13(2):227-8. PubMed ID: 2116554
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma and cerebrospinal fluid amino acid concentrations in phenylketonuria during the newborn period.
    Snyderman SE; Sansaricq C; Norton PM; Castro JV
    J Pediatr; 1981 Jul; 99(1):63-7. PubMed ID: 6788920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The advantage of phenylalanine to tyrosine ratio for the early detection of phenylketonuria.
    Levy PA; Miller JB; Shapira E
    Clin Chim Acta; 1998 Feb; 270(2):177-81. PubMed ID: 9544454
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabolic management and therapeutic results in patients with phenylketonuria].
    Theile H; Bührdel P; Cobet G; Schlenzka K
    Kinderarztl Prax; 1975 Oct; 43(10):442-50. PubMed ID: 1195566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.